Reenav Pharma Private Limited, a active private limited company, was established on 18 April 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2018PTC308208. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Arvind Govind Varia (Director), Rajeshree Trikamlal Gor (Director). Past directors included Anand Subramanian Iyer, Jay Rajesh Mehta, Kalpana Srinivasan. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at 607, 6Th Floor, Skyline Epitome Building Near Jolly Gymkhana, Vidyavihar West,, Mumbai, Maharashtra, 400086.
U74999MH2018PTC308208
308208
18 April 2018
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Reenav Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Govind Varia | Director | 18 Apr 2018 | Current |
| Rajeshree Trikamlal Gor | Director | 18 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Sep 2022 | Past |
| Pramod Abcsdd | Director | 13 May 2022 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reenav Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.24% decrease. The company also saw a substantial fall in profitability, with a 13.09% decrease in profit. The company's net worth Soared by an impressive increase of 48.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Reenav Pharma had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Reenav Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Reenav Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reenav Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Reenav Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Reenav Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Arvind Govind Varia was appointed as a Director was appointed as a Director on 18 Apr 2018 & has been associated with this company since 7 years 7 months . was documented.
Rajeshree Trikamlal Gor was appointed as a Director was appointed as a Director on 18 Apr 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
The activity Reenav Pharma Private Limited was registered on 18 Apr 2018 with Roc Mumbai & aged 7 years 7 months as per MCA records. was completed.
The CIN of Reenav Pharma Private Limited is U74999MH2018PTC308208.
Reenav Pharma Private Limited is headquartered at 607, 6Th Floor, Skyline Epitome Building Near Jolly Gymkhana, Vidyavihar West,, Mumbai, Maharashtra, 400086.
Reenav Pharma Private Limited was incorporated on 18 April 2018.
The current directors of Reenav Pharma Private Limited are
The primary industry of Reenav Pharma Private Limited is Trade.
Reenav Pharma Private Limited is unlisted.
The authorized capital of Reenav Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX